Tekmira on Track to Start Cancer Rx Trial Before Year-End; Cholesterol Drug Still On Hold

The company also said that it may begin another clinical trial of its cancer therapy in a different indication in collaboration with the National Cancer Institute.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.